OKYO Pharma Limited

LSE:OKYO Lagerbericht

Marktkapitalisierung: UK£23.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

OKYO Pharma Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Gary Jacob

Geschäftsführender

UK£1.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts17.5%
Amtszeit als Geschäftsführer2.3yrs
Eigentum des Geschäftsführers0.05%
Durchschnittliche Amtszeit des Managements2.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.3yrs

Jüngste Management Updates

Recent updates

Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Nov 26
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Jan 27
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

Sep 22
Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

Mar 17
We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Dec 02
We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Gary Jacob im Vergleich zu den Einnahmen von OKYO Pharma verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2022n/an/a

-UK£7m

Jun 30 2022n/an/a

-UK£5m

Mar 31 2022UK£1mUK£256k

-UK£4m

Dec 31 2021n/an/a

-UK£4m

Sep 30 2021n/an/a

-UK£4m

Jun 30 2021n/an/a

-UK£3m

Mar 31 2021UK£649kUK£61k

-UK£3m

Vergütung im Vergleich zum Markt: Gary's total compensation ($USD1.82M) is above average for companies of similar size in the UK market ($USD352.33K).

Entschädigung vs. Einkommen: Gary's compensation has increased whilst the company is unprofitable.

Geschäftsführer

Gary Jacob (75 yo)

2.3yrs

Amtszeit

UK£1,467,000

Vergütung

Dr. Gary S. Jacob, PhD, served as an Independent Director at Virpax Pharmaceuticals, Inc. since April 2020 until July 25, 2022. He had been an Independent Director of Cardiff Oncology, Inc. since February...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Gary Jacob
CEO & Executive Director2.3yrsUK£1.47m0.049%
£ 11.4k
Michael Beck
Founderno datakeine Datenkeine Daten
Keeren Shah
Chief Financial Officer2.8yrskeine Daten0%
£ 0
Rajkumar Patil
Chief Scientific Officer2.2yrskeine Daten0%
£ 0

2.3yrs

Durchschnittliche Betriebszugehörigkeit

64yo

Durchschnittliches Alter

Erfahrenes Management: OKYO's management team is considered experienced (2.3 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Gary Jacob
CEO & Executive Director2.3yrsUK£1.47m0.049%
£ 11.4k
Bernard Denoyer
Independent Non-Executive Director1.4yrsUK£14.00kkeine Daten
Gabriele Marco Cerrone
Non-Executive Chairman2.3yrsUK£120.00k33.47%
£ 7.8m
John Brancaccio
Independent Non-Executive Director2.9yrsUK£55.00k0%
£ 0
Jay Pepose
Member of Scientific Advisory Boardless than a yearkeine Datenkeine Daten
Willy Simon
Senior Independent Non-Executive Director7.5yrsUK£35.00k0.019%
£ 4.3k
Napoleone Ferrara
Member of Scientific Advisory Board2.8yrskeine Datenkeine Daten
Pedram Hamrah
Member of Scientific Advisory Boardno datakeine Datenkeine Daten

2.3yrs

Durchschnittliche Betriebszugehörigkeit

71yo

Durchschnittliches Alter

Erfahrener Vorstand: OKYO's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.